4//SEC Filing
Grimes Scott D. 4
Accession 0001666071-22-000050
CIK 0001666071other
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 5:03 PM ET
Size
6.9 KB
Accession
0001666071-22-000050
Insider Transaction Report
Form 4
Cardlytics, Inc.CDLX
Grimes Scott D.
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2022-04-19$50.09/sh−4,098$205,269→ 243,606 total
Holdings
- 55,832(indirect: See Footnote)
Common Stock
- 53,112(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2020, as amended September 15, 2021.
- [F2]The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- [F3]The reportable securities are held by the UTMA Custodial account fbo Pierce Grimes.
- [F4]The reportable securities are held by the 2013 Scott Grimes GRAT UAD.
Documents
Issuer
Cardlytics, Inc.
CIK 0001666071
Entity typeother
Related Parties
1- filerCIK 0001617486
Filing Metadata
- Form type
- 4
- Filed
- Apr 20, 8:00 PM ET
- Accepted
- Apr 21, 5:03 PM ET
- Size
- 6.9 KB